ChemicalBook
English   Japanese   Germany   Korea

N-[(1R)-1-[3′-(Aminocarbonyl)[1,1′-biphenyl]-4-yl]-2-(1-pyrrolidinyl)ethyl]-6,7-dichloro-2,3-dihydro-N-methyl-3-oxo-4H-1,4-benzoxazine-4-acetamide

, 1003877-55-1, 结构式
CAS号:
1003877-55-1
英文名:
N-[(1R)-1-[3′-(Aminocarbonyl)[1,1′-biphenyl]-4-yl]-2-(1-pyrrolidinyl)ethyl]-6,7-dichloro-2,3-dihydro-N-methyl-3-oxo-4H-1,4-benzoxazine-4-acetamide
英文别名:
GSK-1562590;N-[(1R)-1-[3′-(Aminocarbonyl)[1,1′-biphenyl]-4-yl]-2-(1-pyrrolidinyl)ethyl]-6,7-dichloro-2,3-dihydro-N-methyl-3-oxo-4H-1,4-benzoxazine-4-acetamide
中文名:
中文别名:
CBNumber:
CB813786001
分子式:
C30H30Cl2N4O4
分子量:
581.49
MOL File:
1003877-55-1.mol

N-[(1R)-1-[3′-(Aminocarbonyl)[1,1′-biphenyl]-4-yl]-2-(1-pyrrolidinyl)ethyl]-6,7-dichloro-2,3-dihydro-N-methyl-3-oxo-4H-1,4-benzoxazine-4-acetamide化学性质

沸点:
841.6±65.0 °C(Predicted)
密度:
1.347±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)
酸度系数(pKa):
15.84±0.50(Predicted)
安全信息

N-[(1R)-1-[3′-(Aminocarbonyl)[1,1′-biphenyl]-4-yl]-2-(1-pyrrolidinyl)ethyl]-6,7-dichloro-2,3-dihydro-N-methyl-3-oxo-4H-1,4-benzoxazine-4-acetamide性质、用途与生产工艺

N-[(1R)-1-[3′-(Aminocarbonyl)[1,1′-biphenyl]-4-yl]-2-(1-pyrrolidinyl)ethyl]-6,7-dichloro-2,3-dihydro-N-methyl-3-oxo-4H-1,4-benzoxazine-4-acetamide 上下游产品信息

上游原料

下游产品

N-[(1R)-1-[3′-(Aminocarbonyl)[1,1′-biphenyl]-4-yl]-2-(1-pyrrolidinyl)ethyl]-6,7-dichloro-2,3-dihydro-N-methyl-3-oxo-4H-1,4-benzoxazine-4-acetamide 生产厂家

全球有 1家供应商   N-[(1R)-1-[3′-(Aminocarbonyl)[1,1′-biphenyl]-4-yl]-2-(1-pyrrolidinyl)ethyl]-6,7-dichloro-2,3-dihydro-N-methyl-3-oxo-4H-1,4-benzoxazine-4-acetamide国内生产厂家
供应商联系电话电子邮件国家产品数优势度
TargetMol中国（陶术生物） 15002134094 marketing@targetmol.cn 中国 28091 58
 

1003877-55-1, N-[(1R)-1-[3′-(Aminocarbonyl)[1,1′-biphenyl]-4-yl]-2-(1-pyrrolidinyl)ethyl]-6,7-dichloro-2,3-dihydro-N-methyl-3-oxo-4H-1,4-benzoxazine-4-acetamide 相关搜索:

  • 1003877-55-1
  • GSK-1562590
  • N-[(1R)-1-[3′-(Aminocarbonyl)[1,1′-biphenyl]-4-yl]-2-(1-pyrrolidinyl)ethyl]-6,7-dichloro-2,3-dihydro-N-methyl-3-oxo-4H-1,4-benzoxazine-4-acetamide
Copyright 2016 © ChemicalBook. All rights reserved